Sanofi com­mit­ted to speedy re­lease of new medicines

Shanghai Daily - - CIIE -

At the first China In­ter­na­tional Im­port Expo, Sanofi, the world’s lead­ing health care com­pany, said on Wed­nes­day dur­ing the China Health Road Sym­po­sium, that it will in­tro­duce the drugs and vac­cines ex­hib­ited at the im­port expo to China as early as pos­si­ble.

The com­pany will col­lab­o­rate with its part­ners to bring these new drugs to Chi­nese pa­tients, with a fo­cus on com­mu­nity health cen­ters and county hos­pi­tals.

“As one of the first multi­na­tional pharma com­pa­nies mak­ing pres­ence in China, Sanofi has al­ways been com­mit­ted to play­ing an ac­tive role in the coun­try’s health care ecosys­tem over the past 36 years.” Jean-Christophe Poin­teau, coun­try chair of Sanofi China, said.

In­no­va­tion

At the sym­po­sium, Sanofi showed how the new drugs and vac­cines were de­vel­oped. One of the be­hind-the-scene sto­ries which re­ceived sig­nif­i­cant at­ten­tion was that of Auba­gio, launched just prior to the expo.

Auba­gio is the first oral new drug for the treat­ment of mul­ti­ple scle­ro­sis in China. In the past, it usu­ally took a few years for an orig­i­nal new drug to go through all ap­pli­ca­tion pro­cesses to get list­ing ap­proval. In May 2018, mul­ti­ple scle­ro­sis was in­cluded on the “First List of Rare Dis­eases” in China. Thanks to the new pol­icy sup­port, it set a record for the fastest launch of a rare-dis­ease drug in China.

“We sin­cerely thank the Chi­nese govern­ment for its de­ter­mi­na­tion and ef­fort to ac­cel­er­ate the ap­proval of in­no­va­tive drugs, and we pay trib­ute to all ex­perts, es­pe­cially health care prac­ti­tion­ers, for their con­sis­tent sup­port. We will gear up the in­tro­duc­tion of in­no­va­tive drugs and vac­cines in China, and catch up with Europe and the United States in the list­ing sched­ules to ben­e­fit as many Chi­nese pa­tients as pos­si­ble,” Poin­teau said.

By 2025, at least 16 new prod­ucts and in­di­ca­tions are ex­pected to have been launched in China.

Part­ner­ship

De­but­ing these new drugs at the im­port expo is just the first step. At Wed­nes­day’s sym­po­sium, Sanofi and its part­ners ex­plored how medicines, vac­cines and ser­vices can be adapted to the needs of com­mu­nity health cen­ters and county hos­pi­tals.

Rep­re­sen­ta­tives from the China Pre­ven­tive Medicine As­so­ci­a­tion, the As­so­ci­a­tion of China County Hos­pi­tal Pres­i­dents, and county-level health bu­reaus shared their own sto­ries and feel­ings about be­ing the “gate­keep­ers.”

As the first multi­na­tional phar­ma­ceu­ti­cal en­ter­prise to el­e­vate county-level pri­mary health care in 2011, Sanofi is re­spond­ing to the call of cen­tral and lo­cal gov­ern­ments, col­lab­o­rat­ing with in­dus­trial so­ci­eties and as­so­ci­a­tions in a wide range of ar­eas. It teamed up with the Na­tional Health Com­mis­sion stroke pre­ven­tion pro­ject com­mit­tee and the As­so­ci­a­tion of China County Hos­pi­tal Pres­i­dents to build a na­tional net­work for pre­ven­tion and con­trol of strokes and chest pain.

Apart from build­ing a pres­ence in county-level hos­pi­tals, Sanofi is also paving the health road in thou­sands of com­mu­nity health cen­ters across the coun­try.

Pro­fes­sor Zhu Shanzhu, di­rec­tor of the Shang­hai med­i­cal school de­part­ment of general medicine, and Song Jian­ling, a general prac­ti­tioner at the Changfeng com­mu­nity health ser­vice cen­ter in Pu­tuo, joined their pa­tients to share sto­ries about GPs and fam­i­lies.

Prior to the im­port expo, Sanofi launched the China Health Road Pro­gram with the sup­port of its head­quar­ters. The pro­gram tar­gets pri­mary care and pro­vides long-term train­ing for GPs.

At the end of the sym­po­sium, Poin­teau led the com­pany’s China man­age­ment team to place an “In China, for China” seal on a scroll.

He said, “Sanofi greatly ap­pre­ci­ates Pres­i­dent Xi’s con­fi­dence in bol­ster­ing open­ing-up and fos­ter­ing col­lab­o­ra­tion at the CIIE open­ing cer­e­mony. As the world’s lead­ing health care com­pany and an out­stand­ing cor­po­rate cit­i­zen, Sanofi, to­gether with our 9,500 em­ploy­ees, will be ded­i­cated to our mis­sion and strive to safe­guard the health of Chi­nese peo­ple.”

Jean-Christophe Poin­teau, Coun­try Chair of Sanofi China, spoke at the sym­po­sium.

Newspapers in English

Newspapers from China

© PressReader. All rights reserved.